Microbiota and nonalcoholic steatohepatitis (Q35066721)

6 August 2017

title

Microbiota and nonalcoholic steatohepatitis (English)

1 reference

6 August 2017

0 references

5

Atsushi Nakajima

1 reference

6 August 2017

2

Masato Yoneda

1 reference

6 August 2017

Kento Imajo

1

1 reference

6 August 2017

Yuji Ogawa

series ordinal

3

1 reference

6 August 2017

Koichiro Wada

series ordinal

4

1 reference

6 August 2017

publication date

14 December 2013

1 reference

Seminars in Immunopathology

6 August 2017

published in

1 reference

6 August 2017

volume

36

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

115-132

1 reference

The human microbiome project

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

AGA technical review on nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Non-alcoholic steatohepatitis: definitions and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

21 January 2018

From fat to inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The role of cytokines and chemokines in the development of steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Mechanisms of obesity-associated insulin resistance: many choices on the menu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Origin and physiological roles of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Chronic inflammation in obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The liver as an immunological organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Toll-like receptors as targets in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Alcoholic liver disease and the gut-liver axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Sorting out Toll signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

DAMPs, PAMPs and alarmins: all we need to know about danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Pattern recognition receptors: a contemporary view on liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Microbial ecology of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Patterns and scales in gastrointestinal microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

A Genomic View of the Human-Bacteroides thetaiotaomicron Symbiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Glycan foraging in vivo by an intestine-adapted bacterial symbiont

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Hypothalamic Angptl4/Fiaf Is a Novel Regulator of Food Intake and Body Weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Non-alcoholic steatohepatitis in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Nonalcoholic fatty liver disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Insulin resistance: a metabolic pathway to chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Apolipoprotein synthesis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

IRS proteins and the common path to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Insulin signalling and the regulation of glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Prolonged treatment of primary hepatocytes with oleate induces insulin resistance through p38 mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Absence of intestinal microbiota does not protect mice from diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Human gut microbiota in obesity and after gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Methane production during lactulose breath test is associated with gastrointestinal disease presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Non-alcoholic fatty liver disease: lumen–liver interactions and possible role for probiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Chylomicrons promote intestinal absorption of lipopolysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Elevated endotoxin levels in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Lipopolysaccharide triggered TNF-alpha-induced hepatocyte apoptosis in a murine non-alcoholic steatohepatitis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Portal and systemic bacteraemia and endotoxaemia in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Defining the normal bacterial flora of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Bacterial diversity in human subgingival plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Relationship between periodontal infections and systemic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Periodontal disease, tooth loss, and incidence of ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Oral health and mortality risk from pneumonia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Antibiotic resistance profile of the subgingival microbiota following systemic or local tetracycline therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Periodontitis and atherogenesis: causal association or simple coincidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Relationship of bacteremia to toothbrushing in patients with periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Dental flossing and its relationship to transient bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Incidence of bacteremia after chewing, tooth brushing and scaling in individuals with periodontal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Periodontal disease and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Neutrophils and immunity: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Clinical and experimental pancreatic islet transplantation to striated muscle: establishment of a vascular system similar to that in native islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Phagocyte partnership during the onset and resolution of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Pattern recognition receptors and the innate immune response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Innate immunity in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Sterile inflammation: sensing and reacting to damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

How dying cells alert the immune system to danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The sterile inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

High mobility group box 1 protein interacts with multiple Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

HMG1 and 2, and related 'architectural' DNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The extracellular release of HMGB1 during apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Prebiotic effects: metabolic and health benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Infectious complications of acute and chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Nonsurgical approaches for the treatment of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Non-surgical chemotherapeutic treatment strategies for the management of periodontal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

A prospective study of obesity and cancer risk (Sweden).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

The core gut microbiome, energy balance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Common inhibitory serine sites phosphorylated by IRS-1 kinases, triggered by insulin and inducers of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-013-0404-6

Periodontal disease and NIDDM in Pima Indians

21 January 2018

1 reference

12 December 2020

Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth

1 reference

12 December 2020

Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial

1 reference

12 December 2020

Impact of periodontitis on the diabetes-related inflammatory status

1 reference

12 December 2020

Gut-liver axis: a new point of attack to treat chronic liver damage?

1 reference

12 December 2020

[Antibiotic resistance in the subgingival microflora in patients with adult periodontitis. A comparative survey between Spain and the Netherlands]

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver

1 reference

12 December 2020

Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients

1 reference

12 December 2020

Inflammation, stress, and diabetes

1 reference

12 December 2020

DAMPs ramp up drug toxicity

1 reference

12 December 2020

Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis

1 reference

12 December 2020

Periodontitis-atherosclerosis syndrome: an expanded model of pathogenesis

1 reference

12 December 2020

Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition

1 reference

12 December 2020

Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure

1 reference

12 December 2020

Relationship of periodontal bacterium genotypic variations with periodontitis in type 2 diabetic patients

1 reference

12 December 2020

Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease

1 reference

12 December 2020

Poor Oral Health and Coronary Heart Disease

1 reference

12 December 2020

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

1 reference

12 December 2020

Molecular modulation of intestinal epithelial barrier: contribution of microbiota

1 reference

12 December 2020

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

1 reference

12 December 2020

Periodontal Disease Part II: Overview of Treatment Modalities

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

12 December 2020

Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease

1 reference

12 December 2020

Periodontal Disease: The sixth complication of diabetes mellitus

1 reference

12 December 2020

Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening

1 reference

12 December 2020

Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline

1 reference

12 December 2020

Endotoxin and bacteria in portal blood

1 reference

12 December 2020

Developmental microbial ecology of the neonatal gastrointestinal tract

1 reference

12 December 2020

Periodontal Disease Part III: Chemotherapeutics.

1 reference

12 December 2020

Potential pathogenic mechanisms of periodontitis associated pregnancy complications

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

A proposed model linking inflammation to obesity, diabetes, and periodontal infections

1 reference

12 December 2020

Effect of antibiotics in the prevention of jejunoileal bypass-induced liver dysfunction

1 reference

12 December 2020

Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice

1 reference

12 December 2020

[The role of enterogenous endotoxemia in the pathogenesis of non-alcoholic steatohepatitis]

1 reference

12 December 2020

CD14-deficient mice are exquisitely insensitive to the effects of LPS

1 reference

12 December 2020

Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis

1 reference

12 December 2020

10.1007/S00281-013-0404-6

Identifiers

DOI

1 reference

6 August 2017

1 reference